This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) in Focus: Stock Moves 8.2% Higher
by Zacks Equity Research
UnitedHealth Group (UNH) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Stock Market News for Oct 16, 2019
by Zacks Equity Research
Wall Street closed Tuesday's trading session at more than three-week high, thanks to better-than expected third quarter 2019 earnings of mostly major American banks.
Big Bank & Healthcare Earnings, Netflix Q3 Preview & Buy Lululemon Stock - Free Lunch
by Benjamin Rains
Breaking down some of Tuesday's major Q3 earnings results from giants such as JPMorgan Chase and UnitedHealth. A look at what to expect from Netflix's third quarter financials Wednesday. And why Lululemon is a Zacks Rank #1 (Strong Buy) stock...
UnitedHealth Group (UNH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.47% and 1.22%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth (UNH) Q3 Earnings and Revenues Beat, Guidance Up
by Sapna Bagaria
UnitedHealth's (UNH) higher revenues, strength in both segments -- UnitedHealthcare and Optum -- plus membership growth leads to earnings outperformance.
Find Strong Stocks During Q3 Earnings Season with New Analyst Coverage
by Benjamin Rains
As investors and Wall Street prepare for Q3 earnings season and the fourth quarter, one way to find solid investments ideas, with potential for big returns, is to search for stocks that more analysts have started to cover recently....
JNJ, JP Morgan and UnitedHealth all Beat, Goldman Sachs Misses
by David Borun
A strong start to earnings season sends all the major averages up more than 1%
Major Banks To Flood Wall Street with Earnings Data
by Zacks Equity Research
Major Banks To Flood Wall Street with Earnings Data
Bank Holiday Ahead of Q3 Earnings, Trade Negotiations
by Mark Vickery
We may expect lower trading volume overall today, largely due to the heavy reportage of Q3 earnings beginning promptly tomorrow morning.
Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?
by Zacks Equity Research
Strength in UnitedHealth's (UNH) health service segment is likely to reflect in Q3 results.
What's in the Cards for UnitedHealth (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 earnings are expected to be benefited from higher revenues and membership growth.
Will Q3 Earnings Drive Dow ETF Higher?
by Sweta Killa
With most blue-chip companies earnings scheduled over the coming weeks and sentiments being mixed, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.
UnitedHealth Group (UNH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Expands Medicare Offerings in New Counties
by Zacks Equity Research
UnitedHealth (UNH) is offering Medicare Advantage plans in new counties to reach a greater population of retirees.
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $221.24, marking a +0.66% move from the previous day.
Health Insurers Hope to Gain From Executive Order on Medicare
by Sapna Bagaria
President Trump's executive order with focus on Medicare Advantage will probably increase the participation of health insurers in the social benefit program.
Cigna Offers 2020 Medicare Plans with Supplemental Benefits
by Sapna Bagaria
Cigna (CI) is expanding its Medicare Advantage plans across states and counties along with supplemental benefits
UnitedHealth Group (UNH) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $217.21, moving -0.05% from the previous trading session.
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Cigna, Anthem and Humana
WellCare's Unit to Divest Medicaid Health Plans to Anthem
by Zacks Equity Research
WellCare's (WCG) subsidiary to sell specific Medicaid health plans to Anthem prior to its merger with Centene.
3 Health Insurance Stocks Poised to Beat on Earnings in Q3
by Sapna Bagaria
Growth in government and pharmacy benefit management businesses as well as share buybacks should enhance the third-quarter earnings of health insurers.
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, GlaxoSmithKline, Duke and BlackRock
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $225 in the latest trading session, marking a -1.65% move from the prior day.
UnitedHealth to Offer New Medicare Advantage Plan in Bay Area (Revised)
by Zacks Equity Research
UnitedHealth's (UNH) new Medicare Advantage Plan to serve Medicare beneficiaries in Bay Area.
Top Stock Reports for Facebook, UnitedHealth & GlaxoSmithKline
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth Group (UNH) and GlaxoSmithKline (GSK).